Search
for

    Sort by

    Research 271–300 of 1000+

    1. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia The Journal of Urology · 2020 · 3 citations
    2. Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial Molecular genetics and metabolism · 2019 · 3 citations
    3. Why Odds Ratios Can Be Tricky Statistics The Journal of Clinical Psychiatry · 2018 · 3 citations
    4. Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin Experimental and Therapeutic Medicine · 2018 · 3 citations
    5. Phytotherapy in Benign Prostatic Hyperplasia Elsevier eBooks · 2018 · 3 citations
    6. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system Research and reports in urology · 2016 · 3 citations
    7. Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays Phytotherapy Research · 2016 · 3 citations
    8. Is there a relationship between androgenic alopecia and benign prostatic hyperplasia? DOAJ (DOAJ: Directory of Open Access Journals) · 2015 · 3 citations
    9. 5ARIs and PSA: Evidences Urologia Journal · 2014 · 3 citations
    10. Regarding prostate-specific antigen: let's not shoot the messenger QJM · 2011 · 3 citations
    11. Homologous recombination induced by doxazosin mesylate and saw palmetto in the <i>Drosophila</i> wing‐spot test 2011 · 3 citations
    12. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    13. Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359 The Prostate · 1999 · 3 citations
    14. GYNECOMASTIA AFTER FINASTERIDE THERAPY Southern Medical Journal · 1995 · 3 citations
    15. Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus · 2025 · 2 citations
    16. HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors Discover Chemistry. · 2025 · 2 citations
    17. Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats Frontiers in Pharmacology · 2025 · 2 citations
    18. Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases The World Journal of Men s Health · 2024 · 2 citations
    19. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model Al Mustansiriyah Journal of Pharmaceutical Sciences · 2023 · 2 citations
    20. Lipid Profile and 5α-Reductase Inhibition Activity of Proprietary Ultrahigh-Pressure Supercritical Carbon Dioxide and Hexane Saw Palmetto Extracts Uro · 2023 · 2 citations
    21. 5‐Alpha reductase inhibitor related litigation: A legal database review International Journal of Andrology · 2021 · 2 citations
    22. Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis Asian Journal of Andrology · 2021 · 2 citations
    23. Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS 2019 · 2 citations
    24. Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors Indian Journal of Pharmaceutical Education · 2018 · 2 citations
    25. Prescribing to save patients money: Ethical considerations Journal of The American Academy of Dermatology · 2018 · 2 citations
    26. Effects of 5-alpha reductase inhibitors Current Opinion in Urology · 2018 · 2 citations
    27. Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink European Urology · 2017 · 2 citations
    28. Discriminating in favour of or against men with increased risk of finasteride-related side effects? Experimental Dermatology · 2016 · 2 citations
    29. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system DOAJ (DOAJ: Directory of Open Access Journals) · 2016 · 2 citations
    30. Testosterone metabolite nonessential for androgen effects Nature Reviews Endocrinology · 2012 · 2 citations